DeepRhythmAI (DRAI), developed by Medicalgorithmics, is a revolutionary set of deep learning-based algorithms and machine learning techniques that leverage the power of Convolutional Neural Networks(CNNs) and Transformer models to detect and classify ECG data accurately, identifying a wide range of cardiac arrhythmias. It can automatically analyze multichannel ECG Holter, Extended Holter, Event Monitoring, and Mobile Cardiac Telemetry data.
Our technology aims to provide results with unprecedented accuracy and speed to healthcare professionals who need to diagnose and treat abnormal heart rhythms.
Commercially available In Europe, the
US, and Canada. FDA 510(k) cleared, CE Marked, and Health Canada licensed.
MEDICALgorithmics S.A. is a GDPR & HIPPA compliant organization certified under ISO
13485, MDSAP, and ISO/IEC 27001, ensuring the highest safety and quality standards .
DRAI’s performance comes from a vast collection of 250 billion annotated heartbeats and is validated using 30k+ ECG recordings available for our AI research team.
The data is derived from Long-term up to 30 days of Continuous Multichannel ECG recordings.
DRAI speeds up the process of ECG analysis, reducing clinical teams’ workload by up to 65% while maintaining its superior reliability.
DRAI analysis has demonstrated a 14 times lower risk of missed diagnosis of critical arrhythmias compared to the standards in healthcare.
DRAI's algorithms are trained on massive datasets (250 Billion heartbeats) to detect subtle arrhythmias. An independent study proved that the current standard in ECG analysis results in 14 times more errors compared to DRAI. This translates to demonstrably improved patient outcomes.
DRAI automates a significant portion of ECG analysis, freeing up technicians' time for higher-level tasks and complex cases optimizing the workflows by up to 65%.
Our 100% cloud-based solution rapidly analyzes massive datasets, reducing clinical team workload by 65% and ensuring continuous operation with unlimited consecutiv
Our cutting-edge technology was designed to meet the needs of both patients and healthcare providers, offering autonomous ECG analysis with exceptional precision, speed, and accuracy, accelerating the diagnosis of arrhythmias.
DRAI algorithms leverage the latest technologies, such as Transformer Models, to classify arrhythmias with high accuracy and reliability.
DRAI set of algorithms is a 100% cloud-based solution that can be integrated with any external ECG analysis software.
DRAI has been approved by FDA 510(k) as the only AI algorithm suite for integration with third-party medical ECG analysis software. It is also CE Marked and Health Canada licensed.
DRAI can provide results analysis of very long ECG recordings within a few minutes, significantly speeding up the diagnostic process.
EU certificate (Regulation (EU) 2017/745 on Medical Devices)
Notified Body: TÜV Rheinland LGA Products GmbH
Medical Device License issued by Health Canada
FDA cleared (510(k) Premarket Notification)
Administratorem danych jest Medicalgorithmics S.A. z siedzibą w Warszawie (02-001) przy Jerozolimskie 81. Dane będą przetwarzane w celu udzielenia odpowiedzi na wysłane zapytanie (podstawa prawna: uzasadniony interes administratora), marketing (podstawa prawna: uzasadniony interes administratora). Pełny tekst klauzuli można znaleźć na stronie Polityki Prywatności.
About us
Our History
Management Team
Partners
Work with us
Job offers
Recommend an employee
Application form
